Manufacturer record
Athens Life Sciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
24 batches manufactured by Athens Life Sciences (Himachal Pradesh) were declared Not of Standard Quality between May 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 26128A, Hydroquinon Tretinoin& Mometasone Furoate Cream (exp Feb 2028). DTL Baddi (state lab) found it not of standard quality: The Assay of Mometasone Furoate. Listed in the September 2026 alert.
Records by type
24 records linked to Athens Life Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Hydroquinon Tretinoin& Mometasone Furoate Cream | Batch 26128AMfg Mar 2026 · Exp Feb 2028 | The Assay of Mometasone FuroateAssay | DTL BaddiState lab | Sep 2026 |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets) | Batch TG25-2242FMfg Dec 2025 · Exp Nov 2027 | The Content of Serratiopeptidase in the Sample is less (i.e. 32.33% of Stated Amount) than Schedule V Limit. (Schedule V Limit:- Not less than 90% of Stated Amount)Other | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab | Sep 2026 |
| Rabeprazole Gastro-resistant Tablets IP | Batch TG25-1583LMfg Sep 2025 · Exp Aug 2027 | Assay and DissolutionAssay | SDTL, RaipurState lab | Aug 2026 |
| Povidone-Iodine & Metronidazole Ointment | Batch 25343AMfg Aug 2025 · Exp Jul 2027 | ContentOther | DTL, Madurai-19State lab | Jun 2026 |
| Pantoprazole Gastro-resistant Tablets IP | Batch TG25-03290Mfg Feb 2025 · Exp Jan 2027 | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution in Acid Stage for Pantoprazole and Description.Dissolution | RDTL, GuwahatiCDSCO lab | Jun 2026 |
| Cefipodoxime Tablets IP 200mg | Batch TCS25-0238AMfg Aug 2025 · Exp Jul 2027 | DissolutionDissolution | RDTL, Bellary, KarnatakaState lab | May 2026 |
| Rabeprazole Gastro-resistant Tablets IP | Batch TG24-14255Mfg Jun 2024 · Exp May 2026 | Content of Rabeprazole SodiumOther | SDT&RL, BhubaneswarState lab | Mar 2026 |
| Ondansetron Orally Disintegrating Tablets IP 8mg | Batch TG24-0742Mfg Apr 2024 · Exp Mar 2026 | Assay, Disintegration & Dissolution.Assay | DTL, JaipurState lab | Mar 2026 |
| Ambroxol Hydrochloride, Levosalbutamol & Guaiphenesin Syrup | Batch LG24-0413Mfg Mar 2024 · Exp Feb 2026 | The sample does not conform to Manufacturer's specification with respect to tests of Assay of Levosalbutamol and Ambroxol Hydrochloride.Assay | CDL, KolkataCDSCO lab | Feb 2026 |
| Pantoprazole Gastro Resistant Tablets IP | Batch TG25-1814AMfg Oct 2025 · Exp Sep 2027 | Failed Disintegration and Uniformity of weightDisintegration | DTL, PuducherryState lab | Jan 2026 |
| Rabeprazole Gastro-resistant Tablets IP (RABIMIST-20) | Batch TG24-1514EMfg Jul 2024 · Exp Jun 2026 | Test for Dissolution and AssayAssay | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules (Sesarab-DSR Capsules) | Batch CG23-0372FMfg Sep 2023 · Exp Aug 2025 | Assay of Rabeprazole SodiumAssay | CDL KolkataCDSCO lab | Jun 2025 |
| Graficlav 625 Tablets (Amoxycillin & Potassium Clavulanate Tablets IP) | Batch TB24-0753AMfg Nov 2024 · Exp Apr 2026 | Uniformity of Weight of TabletsUniformity of weight/content | State Lab KarnatakaState lab | Jun 2025 |
| Pantoprazole Gastro Resistant Tablets IP (PANCID ? 40) | Batch TG24- 1031CMfg May 2024 · Exp Apr 2026 | DissolutionDissolution | SDTL Agartala, TripuraState lab | Nov 2024 |
| Laxnorm Solution (Lactulose Solution USP) | Batch LG24-0204Mfg Feb 2024 · Exp Jan 2026 | AssayAssay | CDL KolkataCDSCO lab | Aug 2024 |
| KOOCAL-500 Tablets (Calcium with Vitamin D Tablets IP) | Batch TG21-2330Mfg Sep 2021 · Exp Feb 2023 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Jan 2023 |
| KOOCAL-500 (Calcium with Vitamin D Tablets IP) | Batch TG21-2550Mfg Oct 2021 · Exp Mar 2023 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Jan 2023 |
| KOOCAL-500 Tablets (Calcium with Vitamin D Tablets IP) | Batch TG21-2346Mfg Sep 2021 · Exp Feb 2023 | Identification and Assay of ?Vitamin D3?Assay | RDTL GuwahatiState lab | Dec 2022 |
| KOOCAL-500 Tablets (Calcium with Vitamin D Tablets IP) | Batch TG21-2565Mfg Oct 2021 · Exp Mar 2023 | Assay of ?Vitamin D3?Assay | RDTL GuwahatiState lab | Dec 2022 |
| Calcium with Vitamin D Tablets IP KOOCAL-500 | Batch TG21-2539Mfg Oct 2021 · Exp Mar 2023 | ?Identification and Assay/Content of Vitamin D3?Assay | RDTL GuwahatiState lab | Dec 2022 |
| Calcium with Vitamin D Tablets IP KOOCAL-500 | Batch TG21-2564Mfg Oct 2021 · Exp Mar 2023 | ?Identification and Assay of Vitamin D3?Assay | RDTL GuwahatiState lab | Dec 2022 |
| KOOCAL-500 (Calcium with Vitamin D Tablets IP) | Batch TG21-2549Mfg Oct 2021 · Exp Mar 2023 | Identification and Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Sep 2022 |
| Cefixime Dispersible Tablets (Micfox-100 Dt Tablets) | Batch FBT19-186BMfg Jun 2019 · Exp May 2021 | AssayAssay | RDTL ChandigarhState lab | Aug 2020 |
| Telmisartan Tablets I.P. 20 mg. (Ezisartan 20) | Batch VT17-4089Mfg Nov 2017 · Exp Oct 2019 | DissolutionDissolution | RDTL GuwahatiState lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.